MDL-101 preclinical data support efficacy and safety of a differentiated precision medicine approach for LAMA2 Congenital Muscular Dystrophy (LAMA2-CMD) Preclinical data showing that our CRISPR-based epigenetic editing technology regulates the expression of target genes in mammals, suggesting the possibility of clinical efficacy as a therapeutic approach for serious genetic disorders TOKYO & WALTHAM, Mass.–(BUSINESS WIRE)–Modalis … [Read more…]

Research finds that 40% of respondents would discourage others from using facial injectables 35% believe the use of injectables such as dermal fillers create unrealistic beauty standards Meanwhile, 4 out of 5 people (78%) could not always correctly identify people who have used dermal fillers1 ZUG, Switzerland–(BUSINESS WIRE)–New global research,2 sponsored by Galderma and released … [Read more…]

BOSTON–(BUSINESS WIRE)–Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the launch of a follow-on public offering of its ordinary shares and accompanying warrants to purchase its ordinary shares. In addition, Gamida Cell expects to grant the underwriters a 30-day option to purchase up to an … [Read more…]

Spring 2023 Field Trials Program Aims to Expand Product Understanding in Advance of Commercialization; Financing will Fuel Pipeline Growth DAVIS, Calif.–(BUSINESS WIRE)–BioConsortia, Inc. today announces implementation of its largest proprietary field trials program to date, with hundreds of tests planned or already underway for the 2023 field season. These field trials are the final development … [Read more…]

Powered by the Strateos LodeStar™ software, large-scale private cloud labs are being designed and implemented globally MENLO PARK, Calif.–(BUSINESS WIRE)–Strateos, a leading provider of lab automation software and remote access laboratories for life science research, today announced a strategic shift aimed at meeting the growing demand from its life sciences customers seeking to establish on-site … [Read more…]

OMAHA, Neb.–(BUSINESS WIRE)–Vivid Clear Rx, a national pharmacy benefit manager, announced today that it has earned the Utilization Management Accreditation from the National Committee for Quality Assurance (NCQA). NCQA’s Utilization Management accreditation is a quality assessment program that focuses on consumer protection and customer service improvement. Standards recognize organizations that have open access networks and … [Read more…]

Non-Dilutive Funding to Accelerate Development of Artificial Intelligence Driven Handheld DeepView® LONDON & DALLAS–(BUSINESS WIRE)–Spectral MD Holdings, Ltd. (AIM: SMD) (“Spectral MD” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announces today that it has received a $4 million award from … [Read more…]

A Prospective Interventional Multicenter Randomized Controlled Trial MARTINEZ, Calif.–(BUSINESS WIRE)–Investigators today announced completion of patient enrollment in the pharmacokinetic/pharmacodynamic phase of the PURIFY Randomized Clinical Trial (RCT), as required by the US Food Drug Administration. Data is now being collected and analyzed to submit to the FDA toward approval, allowing continuation of this pivotal study. … [Read more…]

OVERLAND PARK, Kan.–(BUSINESS WIRE)–SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, announced today that it will release its fiscal third quarter 2023 financial results prior to market open on Thursday, May 11, 2023. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, … [Read more…]

Presents Highly Qualified Slate of Director Nominees, Including Five Incumbent Board Members and New Independent Candidate David W. Gryska Highlights Significant Positive Momentum to Advance R&D Pipeline and Enhance Shareholder Value Discloses FCM MM HOLDINGS’ Intent to Take Control of the Board Through Nomination of Four Director Candidates FCM’s Nominees Lack Relevant Industry Expertise and … [Read more…]